What Lab Tests May Be Used in Longevity Medicine?
Written by Evergreen Editorial, Evergreen Telehealth
Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth
Published Updated
Quick Answer
There is no single standard longevity lab panel. Clinicians may use tests such as A1c or fasting glucose, a lipid panel, blood counts, kidney and liver function, and thyroid tests, chosen for your history and any treatment. More testing is not always better. Results need clinical interpretation, and a change in a biomarker does not prove a health benefit.

Introduction
When people hear "longevity medicine," they often picture long lists of blood tests. In reality, there is no single standard panel. Which labs make sense depends on your age, health history, medications, symptoms, and the treatments being considered, and many commonly ordered labs are the same ones used in routine preventive care.
This guide explains the lab tests that may be used in longevity medicine, what each can and cannot tell you, and how to avoid the common pitfall of over-testing. It is educational and not a list of tests Evergreen or any specific provider uses. Some programs decide whether labs are needed case by case.
Why Labs Are Used at All
Labs can help a clinician screen for conditions that have no symptoms early on, such as prediabetes or high cholesterol, establish a baseline before starting a treatment, check for conditions that would make a treatment unsafe, and monitor safety or response over time. They are not a substitute for a conversation about your symptoms and goals, and a normal result does not guarantee that you are healthy.
Blood Sugar and Metabolic Health
These are among the best-supported tests for adults.
- Hemoglobin A1c reflects average blood sugar over about three months. An A1c of 5.7% to 6.4% is in the prediabetes range. (1)
- Fasting plasma glucose measures blood sugar after fasting. A level of 100 to 125 mg/dL is in the prediabetes range. (1)
- Oral glucose tolerance test measures how the body handles a sugar load and is used less often.
The U.S. Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in adults ages 35 to 70 who have overweight or obesity, (2) and the American Diabetes Association recommends beginning screening at age 35 for most people, repeating at least every three years if results are normal, and testing earlier for adults with overweight or obesity and additional risk factors. (1) People with prediabetes are generally tested at least yearly. (1) For more on this topic, see What Is Metabolic Health and Why Does It Matter? →. If you are considering a GLP-1 program, What Should I Expect From a GLP-1 Prescription? → explains how the evaluation typically works.
Cholesterol and Cardiovascular Risk
A lipid panel measures total cholesterol, LDL, HDL, and triglycerides and is a standard part of cardiovascular risk assessment. (3) Some clinicians also measure ApoB (a count of cholesterol-carrying particles) or Lp(a) (a genetically influenced particle) to refine risk estimates. How much these add for individual patients is discussed among experts, and they are not required in all guidelines. A high-sensitivity C-reactive protein (hs-CRP) test measures inflammation and can be used alongside other risk factors, but it is not specific to any one condition. Blood pressure, which is not a lab test but is just as important, should be checked regularly.
Blood Counts, Kidney, and Liver Function
A complete blood count (CBC) looks at red cells, white cells, and platelets, and can detect anemia and other problems. A comprehensive metabolic panel (CMP) checks kidney function, liver enzymes, electrolytes, and blood sugar. These tests are often used before starting treatments, and for medicines that are processed by the liver or kidneys they may be repeated. For example, Evergreen's patient guide for low-dose naltrexone notes that a provider may suggest a liver blood test near the start and once a year.
Thyroid, Hormone, and Vitamin Tests
- TSH (thyroid-stimulating hormone) screens for an underactive or overactive thyroid, which can cause fatigue and weight changes. It is also relevant if you take thyroid medicine.
- Sex hormones such as testosterone and estradiol may be tested in people with symptoms of deficiency, and results need to be interpreted alongside symptoms and the timing of the test.
- IGF-1 reflects growth hormone activity and is sometimes measured when growth hormone signaling is being evaluated. A result alone does not show whether treatment is beneficial.
- Vitamin D and B12 are common tests, and deficiencies are treatable. Testing is most useful when you have risk factors or symptoms.
Interpretation matters more than the number. Reference ranges describe what is typical in a lab's population, and "optimal" ranges promoted in some wellness settings are not always backed by outcome data.
What About Biological Age Tests?
Tests that estimate biological age, such as epigenetic clocks, are mainly research tools. Individual results can vary from test to test and over short periods of time, and they lack validated clinical cutoffs. Biological Age vs. Chronological Age: What's the Difference? →
How to Avoid Over-Testing
More testing is not automatically better. Each test has a false-positive rate, and an abnormal result with no clear clinical meaning can lead to more tests, anxiety, or treatment that does not help. A few principles help:
- Test for a reason. Ask what decision the result will inform.
- Repeat sparingly. Many values fluctuate day to day and with fasting, sleep, stress, and illness.
- Look at trends, not single values, and use the same lab when possible.
- Pair numbers with function. Strength, walking speed, sleep, and how you feel matter too.
- Ask about next steps before the test, so you know what an abnormal result would mean.
Learn more about how plans are personalized and how results are tracked: How Are Longevity Treatment Plans Personalized? and How Are Longevity Treatment Results Monitored Over Time?.
Frequently Asked Questions
Do I need labs before starting a longevity treatment? It depends on the treatment, your history, and your provider. Some clinicians order baseline labs, and others decide based on your health questionnaire. Ask what is recommended for you and why.
Is there a standard longevity lab panel? No. There is no single agreed-upon panel. Commonly used tests overlap with routine preventive care, such as blood sugar, cholesterol, blood counts, and kidney and liver function.
Are direct-to-consumer lab tests worth it? They can be convenient, but results are only as useful as the interpretation. Talk with a clinician about what the numbers mean, especially for results outside the typical range.
How often should labs be repeated? It depends on your results, risk factors, and treatments. For example, adults with prediabetes are generally tested at least yearly. (1) Your clinician sets the schedule.
Can labs tell me if a longevity treatment is working? Sometimes they show whether a biomarker changed, but a biomarker change is not the same as a health benefit. How you feel and function also matter.
Learn More About Evergreen Longevity
Evergreen Longevity is Evergreen's clinician-guided program for healthy aging. A licensed provider reviews your history and goals and decides what, if anything, is needed, including whether labs are appropriate. For the bigger picture, read The Complete Guide to Longevity Treatments and Healthy Aging →.
Explore Clinician-Guided Longevity Care. Learn how Evergreen Longevity approaches healthy aging through individualized protocols and ongoing provider monitoring. Explore Evergreen Longevity →
Not every applicant will qualify for every treatment.
References
1. Diabetes diagnosis and screening: American Diabetes Association. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1). https://diabetesjournals.org/care/article/49/Supplement_1/S27/163926/2-Diagnosis-and-Classification-of-Diabetes
2. Diabetes screening recommendation: U.S. Preventive Services Task Force. Screening for prediabetes and type 2 diabetes. 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-prediabetes-and-type-2-diabetes
3. Cholesterol guideline: Grundy SM, et al. 2018 AHA/ACC multisociety guideline on the management of blood cholesterol. Circulation. 2019;139:e1082-e1143. https://pubmed.ncbi.nlm.nih.gov/30586774/
This page is for educational purposes only and is not a substitute for individualized medical advice. Always consult a licensed healthcare provider before starting or stopping any medication. Information and statements on this material have not been evaluated by the Food and Drug Administration. Evergreen Telehealth content is for general education and should never replace professional medical advice that considers your individual health.
Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth, on November 17, 2026.